190 related articles for article (PubMed ID: 8175673)
1. Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2',3'-dideoxynucleoside analogs in resting and activated human cells.
Gao WY; Agbaria R; Driscoll JS; Mitsuya H
J Biol Chem; 1994 Apr; 269(17):12633-8. PubMed ID: 8175673
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.
Perno CF; Yarchoan R; Cooney DA; Hartman NR; Gartner S; Popovic M; Hao Z; Gerrard TL; Wilson YA; Johns DG
J Exp Med; 1988 Sep; 168(3):1111-25. PubMed ID: 2844951
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cells.
Shirasaka T; Chokekijchai S; Yamada A; Gosselin G; Imbach JL; Mitsuya H
Antimicrob Agents Chemother; 1995 Nov; 39(11):2555-9. PubMed ID: 8585744
[TBL] [Abstract][Full Text] [Related]
4. Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells.
Gao WY; Shirasaka T; Johns DG; Broder S; Mitsuya H
J Clin Invest; 1993 May; 91(5):2326-33. PubMed ID: 8387546
[TBL] [Abstract][Full Text] [Related]
5. Anti-human immunodeficiency virus type 1 activities of dideoxynucleoside phosphotriester derivatives in primary monocytes/macrophages.
Thumann-Schweitzer C; Gosselin G; Périgaud C; Benzaria S; Girardet JL; Lefebvre I; Imbach JL; Kirn A; Aubertin AM
Res Virol; 1996; 147(2-3):155-63. PubMed ID: 8901435
[TBL] [Abstract][Full Text] [Related]
6. Lamivudine (3TC) phosphorylation and drug interactions in vitro.
Kewn S; Veal GJ; Hoggard PG; Barry MG; Back DJ
Biochem Pharmacol; 1997 Sep; 54(5):589-95. PubMed ID: 9337075
[TBL] [Abstract][Full Text] [Related]
7. Decreased anti-human immunodeficiency virus type-1 activities of 2',3'-dideoxynucleoside analogs in MOLT-4 cell sublines resistant to 2',3'-dideoxynucleoside analogs.
Cinatl J; Cinatl J; Weber B; Rabenau H; Weissflog A; Mainke M; Kornhuber B; Doerr HW
Acta Virol; 1993 Oct; 37(5):360-8. PubMed ID: 8184788
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine and its activity in combination with clinically approved anti-human immunodeficiency virus beta-D(+) nucleoside analogs in vitro.
Dutschman GE; Bridges EG; Liu SH; Gullen E; Guo X; Kukhanova M; Cheng YC
Antimicrob Agents Chemother; 1998 Jul; 42(7):1799-804. PubMed ID: 9661024
[TBL] [Abstract][Full Text] [Related]
9. Effect of anti-HIV 2'-beta-fluoro-2',3'-dideoxynucleoside analogs on the cellular content of mitochondrial DNA and on lactate production.
Tsai CH; Doong SL; Johns DG; Driscoll JS; Cheng YC
Biochem Pharmacol; 1994 Oct; 48(7):1477-81. PubMed ID: 7945448
[TBL] [Abstract][Full Text] [Related]
10. Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine.
Perno CF; Yarchoan R; Cooney DA; Hartman NR; Webb DS; Hao Z; Mitsuya H; Johns DG; Broder S
J Exp Med; 1989 Mar; 169(3):933-51. PubMed ID: 2538549
[TBL] [Abstract][Full Text] [Related]
11. In vitro anti-HIV-1 activity of HIV protease inhibitor KNI-272 in resting and activated cells: implications for its combined use with AZT or ddI.
Chokekijchai S; Shirasaka T; Weinstein JN; Mitsuya H
Antiviral Res; 1995 Sep; 28(1):25-38. PubMed ID: 8585758
[TBL] [Abstract][Full Text] [Related]
12. Effects of 3'-deoxynucleoside 5'-triphosphate concentrations on chain termination by nucleoside analogs during human immunodeficiency virus type 1 reverse transcription of minus-strand strong-stop DNA.
Arts EJ; Marois JP; Gu Z; Le Grice SF; Wainberg MA
J Virol; 1996 Feb; 70(2):712-20. PubMed ID: 8551607
[TBL] [Abstract][Full Text] [Related]
13. Induction of the SOS response in Escherichia coli by azidothymidine and dideoxynucleosides.
Mamber SW; Brookshire KW; Forenza S
Antimicrob Agents Chemother; 1990 Jun; 34(6):1237-43. PubMed ID: 2118327
[TBL] [Abstract][Full Text] [Related]
14. 3'-Azido-2',3'-dideoxythymidine induced deficiency of thymidine kinases 1, 2 and deoxycytidine kinase in H9 T-lymphoid cells.
Gröschel B; Kaufmann A; Höver G; Cinatl J; Doerr HW; Noordhuis P; Loves WJ; Peters GJ; Cinatl J
Biochem Pharmacol; 2002 Jul; 64(2):239-46. PubMed ID: 12123744
[TBL] [Abstract][Full Text] [Related]
15. Substrate specificity of human deoxycytidine kinase toward antiviral 2',3'-dideoxynucleoside analogs.
Kierdaszuk B; Bohman C; Ullman B; Eriksson S
Biochem Pharmacol; 1992 Jan; 43(2):197-206. PubMed ID: 1739408
[TBL] [Abstract][Full Text] [Related]
16. Effect of nucleoside analogs on neurite regeneration and mitochondrial DNA synthesis in PC-12 cells.
Cui L; Locatelli L; Xie MY; Sommadossi JP
J Pharmacol Exp Ther; 1997 Mar; 280(3):1228-34. PubMed ID: 9067308
[TBL] [Abstract][Full Text] [Related]
17. Effects of bone marrow stimulatory cytokines on human immunodeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures of monocyte/macrophages.
Perno CF; Cooney DA; Gao WY; Hao Z; Johns DG; Foli A; Hartman NR; Caliò R; Broder S; Yarchoan R
Blood; 1992 Aug; 80(4):995-1003. PubMed ID: 1379854
[TBL] [Abstract][Full Text] [Related]
18. Disparate actions of hydroxyurea in potentiation of purine and pyrimidine 2',3'-dideoxynucleoside activities against replication of human immunodeficiency virus.
Gao WY; Johns DG; Chokekuchai S; Mitsuya H
Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8333-7. PubMed ID: 7667290
[TBL] [Abstract][Full Text] [Related]
19. Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives.
Balzarini J
Pharm World Sci; 1994 Apr; 16(2):113-26. PubMed ID: 8032337
[TBL] [Abstract][Full Text] [Related]
20. Targeted therapy of human immunodeficiency virus-related disease.
Mitsuya H; Yarchoan R; Kageyama S; Broder S
FASEB J; 1991 Jul; 5(10):2369-81. PubMed ID: 1712326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]